Dr Haley Ellis from Massachusetts General Hospital in Boston, Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Dr Sara Lonardi from the Veneto Institute of Oncology IOV-IRCCS in Padua, Italy, and Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discuss patient cases and provide their perspectives on clinical datasets informing the care of patients with HER2-positive gastrointestinal cancer. CME information and select publications here...
Jul 15, 2025•1 hr 29 min•Season 24Ep. 31
Dr Andrea Cercek from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, Dr Pashtoon Kasi from City of Hope Orange County in Irvine, California, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, and Dr J Randolph Hecht from the UCLA David Geffen School of Medicine in Santa Monica, California, discuss recent updates on available and novel treatment strategies for colorectal cancer. CME i...
Jul 02, 2025•2 hr 2 min•Season 24Ep. 30
Dr Geoffrey Y Ku from the Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Zev Wainberg from the UCLA School of Medicine discuss patient cases and summarize current treatment approaches for gastroesophageal cancer. CME information and select publications here .
Jun 19, 2025•1 hr 1 min•Season 24Ep. 29
Dr Sunnie Kim and Dr Manish Shah summarize the clinical treatment landscape for patients with gastroesophageal cancers, supported by clinical perspectives and management strategies from oncology nursing experts Ms Brooke Parker and Ms Michal Segal. NCPD information and select publications here .
Jun 12, 2025•1 hr 30 min•Season 24Ep. 28
Clinical investigators discuss available data guiding the management of hepatocellular carcinoma. CME information and select publications here .
Jun 01, 2025•51 min•Season 24Ep. 27
Drs Farshid Dayyani and Philip A Philip and oncology nursing professionals Caroline Kuhlman and Amanda K Wagner discuss datasets guiding treatment decision-making for patients with metastatic pancreatic cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here .
May 30, 2025•1 hr 33 min•Season 24Ep. 26
Clinical investigators discuss available data guiding the management of gastroesophageal cancer. CME information and select publications here .
May 26, 2025•53 min•Season 24Ep. 25
Clinical investigators discuss available data guiding the management of pancreatic cancer. CME information and select publications here .
May 21, 2025•49 min•Season 24Ep. 24
Clinical investigators discuss available data guiding the management of colorectal cancer. CME information and select publications here .
May 17, 2025•50 min•Season 24Ep. 23
Clinical investigators discuss available data guiding the management of biliary tract cancers. CME information and select publications here .
Apr 27, 2025•49 min•Season 24Ep. 22
Clinical investigators discuss available data guiding the management of neuroendocrine tumors. CME information and select publications here .
Apr 11, 2025•50 min•Season 24Ep. 21
Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. CME information and select publications here .
Mar 28, 2025•49 min•Season 24Ep. 20
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston and Dr Jeffrey Meyerhardt from Dana-Farber Cancer Institute in Boston summarize the most clinically relevant research findings and data presented over the past year for patients with colorectal cancer. CME information and select publications here .
Mar 15, 2025•59 min•Season 24Ep. 19
Dr John Bridgewater from the UCL Cancer Institute in London, United Kingdom, discusses patient cases and summarizes current treatment approaches for cholangiocarcinoma and other biliary tract cancers. CME information and select publications here .
Mar 01, 2025•58 min•Season 24Ep. 18
Dr Arvind Dasari, Dr Van Morris, Dr Jenny Seligmann, Prof Eric Van Cutsem and moderator Dr Christopher Lieu summarize research findings guiding the application of biomarker-driven therapy for patients with colorectal cancers during a session at the 2025 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here .
Feb 22, 2025•1 hr 57 min•Season 24Ep. 17
Dr Anthony El-Khoueiry, Dr Richard Finn, Dr Aiwu Ruth He, Dr Stacey Stein and moderator Dr Stephen “Fred” Divers discuss data from the 2025 ASCO GI meeting and other published studies guiding the care of patients with hepatocellular carcinoma. CME information and select publications here .
Feb 14, 2025•1 hr 59 min•Season 24Ep. 16
Dr Christopher Lieu shares his perspectives on the evolving therapeutic landscape for patients with colorectal and gastroesophageal cancers.
Dec 18, 2024•49 min•Season 24Ep. 15
Dr Daneng Li shares his perspectives on the evolving therapeutic landscape for patients with hepatobiliary cancers.
Dec 18, 2024•56 min•Season 24Ep. 14
Dr Tanios Bekaii-Saab from Mayo Clinic in Phoenix, Arizona, and Dr Philip A Philip from the Henry Ford Cancer Institute in Detroit, Michigan, discuss recent research presentations on the treatment of gastrointestinal cancers.
Nov 06, 2024•1 hr 2 min•Season 24Ep. 13
Dr Thierry Alcindor from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for desmoid tumors and review novel options for targeted therapy.
Oct 18, 2024•59 min•Season 24Ep. 12
Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field.
Sep 20, 2024•2 hr 15 min•Season 24Ep. 11
Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.
Sep 19, 2024•59 min•Season 24Ep. 10
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
Sep 13, 2024•1 hr 1 min•Season 24Ep. 9
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.
Sep 10, 2024•1 hr 15 min•Season 24Ep. 8
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.
Jul 16, 2024•1 hr 3 min•Season 24Ep. 7
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
May 03, 2024•1 hr•Season 24Ep. 6
Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
Apr 16, 2024•37 min•Season 24Ep. 5
Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.
Apr 08, 2024•59 min•Season 24Ep. 4
Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers.
Mar 21, 2024•1 hr 2 min•Season 24Ep. 3
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.
Mar 07, 2024•1 hr 3 min•Season 24Ep. 2
